Schedule some time to discuss your ongoing or future projects with our FHI Clinical team members who will be in attendance at the ASTMH 2020 Annual Meeting.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA
Senior Vice President, Global Client Solutions
Claudia Christian has over 25 years’ experience in the execution of global clinical programs. Christian has held multiple positions from fieldwork to executive leadership in biotech, pharma and both large and niche CROs across all phases and multiple indications. She has broad experience managing industry-, government- and grant-funded portfolios.
Christian has successfully participated in executive ownership programs through mergers & acquisitions (M&A) and has a passion for corporate growth targeting challenging international markets with a focus on accessible and sustainable improvements in resource-constrained settings.
Prior to joining FHI Clinical, she served as Vice President, Global Operations for a niche CRO where she was instrumental in developing the commercial pipeline, growing the book of business by 3 times in less than 3 years, completing due diligence and sale well ahead of planned timelines and growing the company valuation by 5 times from inception to point of sale with over 18% growth year over year (YoY) in revenue, a net book to bill of 1.2 (YoY) and gross margin above 26%.
She serves as Senior Vice President of Client Solutions, maximizing performance of a global expanding portfolio of programs and staff across Africa, the Americas and Asia in pandemic and infectious diseases.
Vice President, Global Strategy
With more than twenty years of experience in clinical research monitoring and management, Ghiorghis Belai serves as FHI Clinical’s Vice President, Global Strategy. In this role, Belai is responsible for managing FHI Clinical’s relationships with sponsors and sites, and he works on project feasibility to ensure optimal implementation of trials.
Belai previously served as Director of Clinical Operations for FHI 360, where he managed the clinical research unit based in Nairobi, Kenya, while supervising and mentoring the FHI 360 Africa Regional Clinical Research Unit. In this role, Belai was responsible for reviewing study protocols, coordinating study implementation of multi-center and multi-country trials in Africa, and ensuring that studies adhered to protocol requirements and applicable regulations and guidelines.
With a background in clinical research, Belai has also worked as a clinical research associate for PharmaNet Development Group, Inc., and PPD, where he participated in multiple multi-center clinical research studies, assisted with project data clinical review and management, and presented at investigator meetings for assigned studies. In addition, Belai monitored sites according to applicable standard operating procedures and Food and Drug Administration guidelines and reviewed case report forms for adherence to protocol requirements.
Belai holds a bachelor’s degree in Clinical Laboratory Science from the University of Louisiana at Monroe and a master’s degree in Clinical Research from the University of Liverpool.
As Vice President, Business Development, Jeff Cazeault leads the business development team in driving the expansion of the FHI Clinical’s global sales strategy and portfolio in infectious disease. With a background in global team development and management, strategic partnerships and sales strategy, Cazeault has provided disruptive growth and development in pharmaceutical, biotech, clinical research, healthcare tech, CI/market research and innovative healthcare start-ups for more than 20 years. Cazeault also has extensive experience in the China pharmaceutical market in working with biotech companies in licensing and business development strategy.
Most recently, Cazeault worked as a business development consultant serving biotech clients that included healthcare firms focusing on orphan and rare diseases and healthcare areas of unmet need. Prior to that, Cazeault was Vice President of Business Development at Atlantic Research Group, Inc and his experience also included serving as Head of Global Sales at Eli Global and in various sales leadership roles at Bristol-Myers Squibb Immunology and Boehringer Ingelheim Pharmaceutical.
Cazeault holds a Bachelor’s degree in Psychology from Virginia Wesleyan College and lives with his wife and four children in Wrightsville Beach, NC.
